
News
Novo Nordisk's European stock opened down 4.4%, and the White House is reportedly negotiating for lower prices on weight loss drugs like Ozempic from Novo Nordisk

Novo Nordisk's European stock opened down 4.4%, and the White House is reportedly negotiating for lower prices on weight loss drugs like Ozempic from Novo Nordisk